Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/26/2013USRE44613 N-substituted glycine derivatives: hydroxylase inhibitors
11/26/2013US8592648 Seed treatment with combinations of pyrethrins/pyrethroids and thiamethoxam
11/26/2013US8592629 Sulfonamide derivatives as Nav 1.7 inhibitors
11/26/2013US8592611 Trioxane dimer sulfur compounds
11/26/2013US8592608 Triple reuptake inhibitors and methods of their use
11/26/2013US8592591 Fused bicyclic imidazoles
11/26/2013US8592589 Methods of treating cancer with a thieno[3,2-C]pyridine
11/26/2013US8592584 Compositions and methods including cell death inducers and procaspase activation
11/26/2013US8592581 Trisubstituted purine derivatives
11/26/2013US8592580 Substituted triazinone derivatives
11/26/2013US8592579 Pyrrolotriazine kinase inhibitors
11/26/2013US8592571 RNAi modulation of APOB and uses thereof
11/26/2013US8592566 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
11/26/2013US8592489 Storage-stable compositions of glycerol monoalkyl ethers
11/26/2013US8592488 Diarylalkanes as potent inhibitors of binuclear enzymes
11/26/2013US8592487 Deuterated darunavir
11/26/2013US8592486 Compounds for inflammation and immune-related uses
11/26/2013US8592485 Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders
11/26/2013US8592483 Method for treating schizophrenia
11/26/2013US8592482 CCR3 inhibition for ocular angiogenesis and macular degeneration
11/26/2013US8592481 Gastric retentive gabapentin dosage forms and methods for using same
11/26/2013US8592480 Liquid compositions of calcium acetate
11/26/2013US8592477 Polymorphic form of rotigotine and process for production
11/26/2013US8592476 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
11/26/2013US8592475 Inhibitors of Akt activity
11/26/2013US8592474 Process for the preparation or purification of olmesartan medoxomil
11/26/2013US8592473 Triazol compounds for treating biofilm formation
11/26/2013US8592471 Substituted phenylureas and phenylamides as vanilloid receptor ligands
11/26/2013US8592469 Diazonamide analogs
11/26/2013US8592468 Bacterial thioredoxin reductase inhibitors and methods for use thereof
11/26/2013US8592467 Benzothiazole cyclobutyl amine derivatives
11/26/2013US8592466 Methods for treating conditions caused by higher-than-normal dopaminergic activity in basal ganglia
11/26/2013US8592465 Compounds for treatment of cancer
11/26/2013US8592464 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
11/26/2013US8592463 Hedgehog pathway antagonists and therapeutic applications thereof
11/26/2013US8592462 Pirfenidone treatment for patients with atypical liver function
11/26/2013US8592460 Amino-pyridine derivatives as S1P1 /EDG1 receptor agonists
11/26/2013US8592459 Substituted benzimidazoles and methods of their use
11/26/2013US8592458 Alpha7 nicotinic receptor selective ligands
11/26/2013US8592457 Isonicotinamide orexin receptor antagonists
11/26/2013US8592456 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
11/26/2013US8592455 Kinase inhibitors and methods of their use
11/26/2013US8592454 Nitrogen-containing heterocyclic compound and use of same
11/26/2013US8592453 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
11/26/2013US8592452 Cyclic amine compound
11/26/2013US8592451 Reversible nondepolarizing neuromuscular blockade agents and methods for their use
11/26/2013US8592450 Compositions and methods for treatment of eye disorders
11/26/2013US8592449 Radiolabelled phenylimidazole-based ligands
11/26/2013US8592448 Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
11/26/2013US8592447 Acridone compounds
11/26/2013US8592446 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
11/26/2013US8592445 Iso-ergoline derivatives
11/26/2013US8592444 Spirocyclic derivatives as histone deacetylase inhibitors
11/26/2013US8592443 Use of 4 cyclopropylmethoxy-N-(3,5 dichloro-1 oxido-pyridin-4 yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
11/26/2013US8592442 Nilotinib HCl crystalline forms
11/26/2013US8592441 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
11/26/2013US8592440 Crystalline form I of imatinib mesylate
11/26/2013US8592439 Long-term treatment of symptomatic heart failure
11/26/2013US8592437 Heteroarylamide pyrimidone compounds
11/26/2013US8592436 Arylamide pyrimidone derivatives
11/26/2013US8592435 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/26/2013US8592434 Mucoadhesive buccal tablets for the treatment of orofacial herpes
11/26/2013US8592433 Compounds and compositions as protein kinase inhibitors
11/26/2013US8592432 Compounds and compositions as protein kinase inhibitors
11/26/2013US8592431 Fused ring compound and use thereof
11/26/2013US8592430 Quinazolin-oxime derivatives as Hsp90 inhibitors
11/26/2013US8592429 5-amino-4-hydroxypentoyl amides
11/26/2013US8592428 Acetyl pyrrolidinyl indole derivative
11/26/2013US8592427 Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
11/26/2013US8592426 Aryl-benzocycloalkyl amide derivatives
11/26/2013US8592425 Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors
11/26/2013US8592424 Topical regional neuro-affective therapy
11/26/2013US8592422 Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors
11/26/2013US8592421 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
11/26/2013US8592420 Method of treating an anxiety disorder
11/26/2013US8592419 Ceramides and apoptosis-signaling ligand
11/26/2013US8592417 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhibitors
11/26/2013US8592416 Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors
11/26/2013US8592415 Selective kinase inhibitors
11/26/2013US8592414 JNK inhibitors for the treatment of endometriosis
11/26/2013US8592413 Therapeutic substituted cyclopentanes
11/26/2013US8592410 Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
11/26/2013US8592409 Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
11/26/2013US8592408 Fused aminodihydrothiazine derivatives
11/26/2013US8592407 Pyrrolo[2,1-c][1,4] benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof
11/26/2013US8592404 Derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
11/26/2013US8592403 Diazepine and diazocane compounds as MC4 agonists
11/26/2013US8592402 Compounds as lysophosphatidic acid receptor antagonists
11/26/2013US8592401 Methods and compounds for vitamin D therapy
11/26/2013US8592400 Drug combinations containing PDE4 inhibitors and NSAIDs
11/26/2013US8592399 S1P receptors modulators and their use thereof
11/26/2013US8592398 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/26/2013US8592397 Compositions and methods for combination antiviral therapy
11/26/2013US8592396 Glucokinase activators and methods of using same
11/26/2013US8592395 Therapeutic compounds
11/26/2013US8592394 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
11/26/2013US8592393 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
11/26/2013US8592392 Multiple antioxidant micronutrients
11/26/2013US8592391 Method for therapeutic, clinical and veterinary use poly-ICLC
11/26/2013US8592386 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 7860